Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
about
The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascadeImmunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyDICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathwaySevere infectious diseases of childhood as monogenic inborn errors of immunityDifferential impact of Toll-like receptor signaling on distinct B cell subpopulationsDeconstructing innate immune signaling in myelodysplastic syndromesRole of innate immunity in neonatal infectionThe TLR and IL-1 signalling network at a glancePrimary immunodeficiency for the primary care providerNeutrophils: Between host defence, immune modulation, and tissue injuryIgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patientsAge-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infantsPatterns of Allergic Sensitization in High IgE Syndromes.IRAK4 Deficiency in a Patient with Recurrent Pneumococcal Infections: Case Report and Review of the Literature.Clearance of Pneumocystis murina infection is not dependent on MyD88B cell TLRs and induction of immunoglobulin class-switch DNA recombination.A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.Essential role of interleukin-1 signaling in host defenses against group B streptococcus.TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteinsA Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and DiseaseControl of Toll-like receptor-mediated T cell-independent type 1 antibody responses by the inducible nuclear protein IκB-ζNeutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in miceIRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensA narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.Invasive pneumococcal diseases in children and adolescents--a single centre experienceRecurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus.NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kindDynamics of lung defense in pneumonia: resistance, resilience, and remodeling.Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control studyInnate immune responses to Pseudomonas aeruginosa infection.Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.Toll-like receptor genetic variants are associated with Gram-negative infections in VLBW infants.
P2860
Q24299592-D66CC7F3-BA4B-41AD-8721-19A493BA441EQ24301912-73F2838D-B93A-4434-A0D7-BB3C325C1B24Q24621930-EEB8F3B2-A3DA-473F-B1FD-125FAC276E47Q24632504-29BA0070-4F25-4808-8052-51E3C67B7817Q26775891-24E29957-5F40-4A83-BBB8-54348104DB81Q26825241-38455A3A-0E66-4AF7-8EF6-0AE769D60ED3Q26991974-5CC8E799-A331-4513-98DE-56335572D31CQ26999064-A0977D67-9E4C-4DF3-9941-613D31A53DC1Q27013358-49CF86B5-DC05-491C-9E08-1BE2CCCEF222Q28066058-5E3514F7-129E-4D2C-A5A5-BB2D085F10DDQ28087227-45CFE391-6E65-4706-A2F1-9997C6E3F3EEQ28710292-8DE20058-0D0F-4254-9FB7-9125431C6A51Q28741059-DB10D5E1-2AD2-4CFC-A99C-25F66612A6A5Q30278478-0A026EFB-FA73-49DD-ADAB-95C7AD69191EQ33611375-5E1C1CF8-46CE-4A4C-9F79-82B0455F168FQ33807392-E54E7F14-FE03-4620-9354-8B32C98DB7A8Q33893517-8EB34E16-D2C2-47E3-B9CC-DB3F28664CB9Q34044755-C57E141E-5F31-485E-8868-4AF53D3DEC57Q34197495-4E37B10E-154A-46E3-ACEC-4B5013B535B4Q34222038-910AB2D3-453F-4DD0-978C-5F2111297248Q34345726-CE363E31-ECE6-4E9F-92BC-86D11F38F461Q34419556-590A41A5-53D2-489D-A34F-13B4BF2AC244Q34467437-B83DAD7E-52D1-4554-B3B5-FE2F91C14A54Q34499405-C20CD9C3-AEB3-4C53-B6CA-1BF5DAC0A898Q34636867-39ACF724-ECD4-417E-BDA5-32F029D2F0E4Q34795980-B01F6111-14F7-4027-AA29-CBFDDAA65AF0Q34976606-ED7DFE10-FCC9-45D4-AC50-1CAACA5F4535Q35090141-5923B0D4-498B-4EB9-8762-595D28AE2178Q35119564-27A8D827-0182-4542-AD6A-36B8C287AE3FQ35147583-F574CC40-4D28-41F2-A828-A85FD46C535CQ35183900-B14189A6-1803-40D0-9E75-A7C5579F739EQ35187585-73834242-383B-40BB-B8E1-71900C30E1CBQ35190204-A89E96B5-077B-4EB9-8AE4-8D5E15E55163Q35190461-39DC5437-7436-4BAB-BAE3-5AC16AC9817CQ35196768-D18A6423-B3D3-4733-831F-29D2F2471853Q35237500-EA9E9385-4962-416F-96DF-325503A6F74AQ35462598-9445E7B6-4D7A-4F52-855D-5185A399E9D6Q35566398-A00B95F1-3D62-436B-9D29-711FB44DB195Q35671268-2E2EC9D6-B079-4D53-AACE-53D970F06632Q35736420-8861D618-49BB-4D84-AEAF-C2C8743430FE
P2860
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@ast
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@en
type
label
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@ast
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@en
prefLabel
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@ast
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@en
P2093
P2860
P50
P1433
P1476
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
@en
P2093
Abdulaziz Al-Ghonaium
Andrew C Issekutz
Artur Bonito Vitor
Ben-Zion Garty
C Buddy Creech
Carlos Rodriguez-Gallego
Chaim Roifman
Cheng-Lung Ku
Claire Bethune
Claudia Fortuny
P2860
P304
P356
10.1097/MD.0B013E3181FD8EC3
P407
P50
P577
2010-11-01T00:00:00Z